Original language | English |
---|---|
Publisher | BMJ Publishing Group Ltd |
Publication status | Published - 1 May 2020 |
OP0223 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PSA-2): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL
MC Genovese, A Lertratanakul, J Anderson, K Papp, W Tillett, F Van den Bosch, S Tsuji, E Dokoupilova, M Keiserman, X Wang
Research output: Other contribution